A citation-based method for searching scientific literature

Tara T Lineweaver, Mark W Bondi, Douglas Galasko, David P Salmon. Am J Psychiatry 2014
Times Cited: 60







List of co-cited articles
328 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Disclosure of APOE genotype for risk of Alzheimer's disease.
Robert C Green, J Scott Roberts, L Adrienne Cupples, Norman R Relkin, Peter J Whitehouse, Tamsen Brown, Susan LaRusse Eckert, Melissa Butson, A Dessa Sadovnick, Kimberly A Quaid,[...]. N Engl J Med 2009
317
40

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Reisa A Sperling, Paul S Aisen, Laurel A Beckett, David A Bennett, Suzanne Craft, Anne M Fagan, Takeshi Iwatsubo, Clifford R Jack, Jeffrey Kaye, Thomas J Montine,[...]. Alzheimers Dement 2011
23

Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study.
Serena Chao, J Scott Roberts, Theresa M Marteau, Rebecca Silliman, L Adrienne Cupples, Robert C Green. Alzheimer Dis Assoc Disord 2008
162
15

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Marilyn S Albert, Steven T DeKosky, Dennis Dickson, Bruno Dubois, Howard H Feldman, Nick C Fox, Anthony Gamst, David M Holtzman, William J Jagust, Ronald C Petersen,[...]. Alzheimers Dement 2011
11

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.
B Winblad, K Palmer, M Kivipelto, V Jelic, L Fratiglioni, L-O Wahlund, A Nordberg, L Bäckman, M Albert, O Almkvist,[...]. J Intern Med 2004
11

The A4 study: stopping AD before symptoms begin?
Reisa A Sperling, Dorene M Rentz, Keith A Johnson, Jason Karlawish, Michael Donohue, David P Salmon, Paul Aisen. Sci Transl Med 2014
422
11

Clinical and biomarker changes in dominantly inherited Alzheimer's disease.
Randall J Bateman, Chengjie Xiong, Tammie L S Benzinger, Anne M Fagan, Alison Goate, Nick C Fox, Daniel S Marcus, Nigel J Cairns, Xianyun Xie, Tyler M Blazey,[...]. N Engl J Med 2012
11


The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Guy M McKhann, David S Knopman, Howard Chertkow, Bradley T Hyman, Clifford R Jack, Claudia H Kawas, William E Klunk, Walter J Koroshetz, Jennifer J Manly, Richard Mayeux,[...]. Alzheimers Dement 2011
10

Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.
Eric M Reiman, Jessica B S Langbaum, Adam S Fleisher, Richard J Caselli, Kewei Chen, Napatkamon Ayutyanont, Yakeel T Quiroz, Kenneth S Kosik, Francisco Lopera, Pierre N Tariot. J Alzheimers Dis 2011
255
10

Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors.
Jill S Goldman, Susan E Hahn, Jennifer Williamson Catania, Susan LaRusse-Eckert, Melissa Barber Butson, Malia Rumbaugh, Michelle N Strecker, J Scott Roberts, Wylie Burke, Richard Mayeux,[...]. Genet Med 2011
171
10

Willingness-to-pay for predictive tests with no immediate treatment implications: a survey of US residents.
Peter J Neumann, Joshua T Cohen, James K Hammitt, Thomas W Concannon, Hannah R Auerbach, Chihui Fang, David M Kent. Health Econ 2012
83
10

Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials.
Scott Y H Kim, Jason Karlawish, Benjamin E Berkman. Neurology 2015
28
21

Effect of Alzheimer disease genetic risk disclosure on dietary supplement use.
Jacqueline A Vernarelli, J Scott Roberts, Susan Hiraki, Clara A Chen, L Adrienne Cupples, Robert C Green. Am J Clin Nutr 2010
48
12



Are empirically-derived subtypes of mild cognitive impairment consistent with conventional subtypes?
Lindsay R Clark, Lisa Delano-Wood, David J Libon, Carrie R McDonald, Daniel A Nation, Katherine J Bangen, Amy J Jak, Rhoda Au, David P Salmon, Mark W Bondi. J Int Neuropsychol Soc 2013
89
8

Subjective memory complaints and cognitive impairment in older people.
Louise M Reid, Alasdair M J Maclullich. Dement Geriatr Cogn Disord 2006
382
8

Mild cognitive impairment: clinical characterization and outcome.
R C Petersen, G E Smith, S C Waring, R J Ivnik, E G Tangalos, E Kokmen. Arch Neurol 1999
8


ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet Med 2013
8


Return of genomic results to research participants: the floor, the ceiling, and the choices in between.
Gail P Jarvik, Laura M Amendola, Jonathan S Berg, Kyle Brothers, Ellen W Clayton, Wendy Chung, Barbara J Evans, James P Evans, Stephanie M Fullerton, Carlos J Gallego,[...]. Am J Hum Genet 2014
241
8

Using AD biomarker research results for clinical care: a survey of ADNI investigators.
Melanie B Shulman, Kristin Harkins, Robert C Green, Jason Karlawish. Neurology 2013
27
18

Should we disclose amyloid imaging results to cognitively normal individuals?
Joshua D Grill, David K Johnson, Jeffrey M Burns. Neurodegener Dis Manag 2013
23
21

Disclosure of amyloid imaging results to research participants: has the time come?
Jennifer H Lingler, William E Klunk. Alzheimers Dement 2013
29
17

Amyloid imaging, risk disclosure and Alzheimer's disease: ethical and practical issues.
J Scott Roberts, Laura B Dunn, Gil D Rabinovici. Neurodegener Dis Manag 2013
31
16

Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association.
Keith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, Kevin J Donohoe, Norman L Foster, Peter Herscovitch, Jason H Karlawish, Christopher C Rowe, Maria C Carrillo, Dean M Hartley,[...]. Alzheimers Dement 2013
279
8

Would you want to know? Public attitudes on early diagnostic testing for Alzheimer's disease.
Elizabeth M Wikler, Robert J Blendon, John M Benson. Alzheimers Res Ther 2013
27
18

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease.
Frank Jessen, Rebecca E Amariglio, Martin van Boxtel, Monique Breteler, Mathieu Ceccaldi, Gaël Chételat, Bruno Dubois, Carole Dufouil, Kathryn A Ellis, Wiesje M van der Flier,[...]. Alzheimers Dement 2014
8

Public perceptions of presymptomatic testing for Alzheimer disease.
Richard J Caselli, Jessica Langbaum, Gary E Marchant, Rachel A Lindor, Katherine S Hunt, Bruce R Henslin, Amylou C Dueck, Jason S Robert. Mayo Clin Proc 2014
31
16


Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior.
Cathleen D Zick, Charles J Mathews, J Scott Roberts, Robert Cook-Deegan, Robert J Pokorski, Robert C Green. Health Aff (Millwood) 2005
75
8



Quantification of five neuropsychological approaches to defining mild cognitive impairment.
Amy J Jak, Mark W Bondi, Lisa Delano-Wood, Christina Wierenga, Jody Corey-Bloom, David P Salmon, Dean C Delis. Am J Geriatr Psychiatry 2009
345
6

Differential memory test sensitivity for diagnosing amnestic mild cognitive impairment and predicting conversion to Alzheimer's disease.
Laura A Rabin, Nadia Paré, Andrew J Saykin, Michael J Brown, Heather A Wishart, Laura A Flashman, Robert B Santulli. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2009
151
6

Development and validation of a geriatric depression screening scale: a preliminary report.
J A Yesavage, T L Brink, T L Rose, O Lum, V Huang, M Adey, V O Leirer. J Psychiatr Res 1982
6


Base rates of "impaired" neuropsychological test performance among healthy older adults.
B W Palmer, K B Boone, I M Lesser, M A Wohl. Arch Clin Neuropsychol 1998
94
6

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
E H Corder, A M Saunders, W J Strittmatter, D E Schmechel, P C Gaskell, G W Small, A D Roses, J L Haines, M A Pericak-Vance. Science 1993
6


Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors.
Emily C Edmonds, Lisa Delano-Wood, Lindsay R Clark, Amy J Jak, Daniel A Nation, Carrie R McDonald, David J Libon, Rhoda Au, Douglas Galasko, David P Salmon,[...]. Alzheimers Dement 2015
127
6

Factors affecting subjective memory complaints in the AIBL aging study: biomarkers, memory, affect, and age.
R Buckley, M M Saling, D Ames, C C Rowe, N T Lautenschlager, S L Macaulay, R N Martins, C L Masters, T O'Meara, G Savage,[...]. Int Psychogeriatr 2013
108
6

Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates.
Mark W Bondi, Emily C Edmonds, Amy J Jak, Lindsay R Clark, Lisa Delano-Wood, Carrie R McDonald, Daniel A Nation, David J Libon, Rhoda Au, Douglas Galasko,[...]. J Alzheimers Dis 2014
265
6

The source of cognitive complaints predicts diagnostic conversion differentially among nondemented older adults.
Katherine A Gifford, Dandan Liu, Zengqi Lu, Yorghos Tripodis, Nicole G Cantwell, Joseph Palmisano, Neil Kowall, Angela L Jefferson. Alzheimers Dement 2014
84
6



Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease.
Michael R Cassidy, J Scott Roberts, Thomas D Bird, Ellen J Steinbart, L Adrienne Cupples, Clara A Chen, Erin Linnenbringer, Robert C Green. Alzheimers Dement 2008
26
15

Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association.
Keith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, Kevin J Donohoe, Norman L Foster, Peter Herscovitch, Jason H Karlawish, Christopher C Rowe, Maria C Carrillo, Dean M Hartley,[...]. J Nucl Med 2013
153
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.